SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-003473
Filing Date
2023-03-10
Accepted
2023-03-10 16:17:54
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K olma-20230310x8k.htm   iXBRL 8-K 35470
  Complete submission text file 0001558370-23-003473.txt   154474

Data Files

Seq Description Document Type Size
2 EX-101.SCH olma-20230310.xsd EX-101.SCH 3120
3 EX-101.LAB olma-20230310_lab.xml EX-101.LAB 15927
4 EX-101.PRE olma-20230310_pre.xml EX-101.PRE 10052
6 EXTRACTED XBRL INSTANCE DOCUMENT olma-20230310x8k_htm.xml XML 4867
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 23723883
SIC: 2834 Pharmaceutical Preparations